Abstract
The role of tissue engineering in the cystectomy population rests on the principle of sparing healthy intestinal tissue while replacing diseased bladder. Over the last 25 years advances in cell biology and material science have improved the quality and durability of bladder replacement in animals. The neo-urinary conduit ([NUC]-Tengion) employs autologous fat smooth muscle cells which are seeded onto synthetic, biodegradable scaffolds. This seeded construct is then implanted in the patient and purportedly regenerates native urinary tissue to serve as a passive channel connecting the ureters to the skin surface. Preclinical animal studies as well as the first phase I human trial implanting the NUC are reviewed. While the ultimate goal of creating a durable, effective, tissue-engineered conduit is still in its infancy, important technical and experimental strides have been made.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Roberts WC. Facts and ideas from anywhere. Proc (Bayl Univ Med Cent). 2009;22:377–84.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27:289–93.
Based on unpublished analyses in the American College of Surgeons National Surgical Quality Improvement Program Dataset. Shabsigh A, Korets R, Vora KC et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55: 164-174.
Farnham SB, Cookson MS, Alberts G, Smith Jr JA, Chang SS. Benefit of radical cystectomy in the elderly patient with significant co-morbidities. Urol Oncol. 2004;22:178–81.
Kim SP, Shah ND, Weight CJ, et al. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. BJU Int. 2013;112:478–84.
Kim BS, Baez CE, Atala A. Biomaterials for tissue engineering. World J Urol. 2000;18:2–9.
Farhat WA, Yeger H. Does mechanical stimulation have any role in urinary bladder tissue engineering? World J Urol. 2008;26:301–5.
Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 1998;16:224–30.
Song L, Murphy SV, Yang B, Xu Y, Zhang Y, Atala A. Bladder acellular matrix and its application in bladder augmentation. Tissue Eng Part B, Rev. 2014;20:163–72.
Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol. 1996;156:571–7.
Yang B, Zhang Y, Zhou L, et al. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng Part C, Methods. 2010;16:1201–11.
Chun SY, Lim GJ, Kwon TG, et al. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials. 2007;28:4251–6.
Chen F, Yoo JJ, Atala A. Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. Urology. 1999;54:407–10.
Horst M, Madduri S, Gobet R, et al. Engineering functional bladder tissues. J Tissue Eng Regen Med. 2013;7:515–22.
Engelhardt EM, Stegberg E, Brown RA, et al. Compressed collagen gel: a novel scaffold for human bladder cells. J Tissue Eng Regen Med. 2010;4:123–30.
Mauney JR, Cannon GM, Lovett ML, et al. Evaluation of gel spun silk-based biomaterials in a murine model of bladder augmentation. Biomaterials. 2011;32:808–18.
Ajalloueian F, Zeiai S, Fossum M, Hilborn JG. Constructs of electrospun PLGA, compressed collagen and minced urothelium for minimally manipulated autologous bladder tissue expansion. Biomaterials. 2014;35:5741–8.
Pattison MA, Wurster S, Webster TJ, Haberstroh KM. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials. 2005;26:2491–500.
Webb AR, Yang J, Ameer GA. Biodegradable polyester elastomers in tissue engineering. Exp Opin Biol Ther. 2004;4:801–12.
Heffernan MJ, Murthy N. Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. Bioconjugate Chem. 2005;16:1340–2.
Engelhardt EM, Micol LA, Houis S, et al. A collagen-poly(lactic acid-co-varepsilon-caprolactone) hybrid scaffold for bladder tissue regeneration. Biomaterials. 2011;32:3969–76.
Eberli D, Freitas Filho L, Atala A, Yoo JJ. Composite scaffolds for the engineering of hollow organs and tissues. Methods. 2009;47:109–15.
Basu J, Jayo MJ, Ilagan RM, et al. Regeneration of native-like neo-urinary tissue from nonbladder cell sources. Tissue Eng Part A. 2012;18:1025–34.
Drewa T. The artificial conduit for urinary diversion in rats: a preliminary study. Transplant Proc. 2007;39:1647–51.
Geutjes P, Roelofs L, Hoogenkamp H, et al. Tissue engineered tubular construct for urinary diversion in a preclinical porcine model. J Urol. 2012;188:653–60. This study represents one of the first preclinical animal models of a collagen-polymer conduit being utilized for bladder replacement.
Liao W, Yang S, Song C, et al. Tissue-engineered tubular graft for urinary diversion after radical cystectomy in rabbits. J Surg Res. 2013;182:185–91.
Sloff M, de Vries R, Geutjes P, et al. Tissue engineering in animal models for urinary diversion: a systematic review. PLoS One. 2014;9:e98734.
Bodin A, Bharadwaj S, Wu S, Gatenholm P, Atala A, Zhang Y. Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion. Biomaterials. 2010;31:8889–901.
Reinfeldt Engberg G, Lundberg J, Chamorro CI, Nordenskjold A, Fossum M. Transplantation of autologous minced bladder mucosa for a one-step reconstruction of a tissue engineered bladder conduit. Biomed Res Int. 2013;2013:212734.
Oberpenning F, Meng J, Yoo JJ, Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol. 1999;17:149–55.
Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367:1241–6.
Liao WB, Song C, Li YW, Yang SX, Meng LC, Li XH. Tissue-engineered conduit using bladder acellular matrix and bladder epithelial cells for urinary diversion in rabbits. Chin Med J (Engl). 2013;126:335–9.
Baumert H, Simon P, Hekmati M, et al. Development of a seeded scaffold in the great omentum: feasibility of an in vivo bioreactor for bladder tissue engineering. Eur Urol. 2007;52:884–90.
Drewa T, Adamowicz J, Sharma A. Tissue engineering for the oncologic urinary bladder. Nat Rev Urol. 2012;9:561–72.
Aboushwareb T, Atala A. Stem cells in urology. Nat Clin Pract Urol. 2008;5:621–31.
Drewa T, Adamowicz J, Sharma A. Tissue engineering for the oncologic urinary bladder. Nat Rev Urol. 2012;9:561–72.
Frimberger D, Morales N, Gearhart JD, Gearhart JP, Lakshmanan Y. Human embryoid body-derived stem cells in tissue engineering-enhanced migration in co-culture with bladder smooth muscle and urothelium. Urology. 2006;67:1298–303.
Frimberger D, Morales N, Shamblott M, Gearhart JD, Gearhart JP, Lakshmanan Y. Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology. 2005;65:827–32.
Lakshmanan Y, Frimberger D, Gearhart JD, Gearhart JP. Human embryoid body-derived stem cells in co-culture with bladder smooth muscle and urothelium. Urology. 2005;65:821–6.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–20.
Moad M, Pal D, Hepburn AC, et al. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Eur Urol. 2013;64:753–61.
Osborn SL, Thangappan R, Luria A, Lee JH, Nolta J, Kurzrock EA. Induction of human embryonic and induced pluripotent stem cells into urothelium. Stem Cells Transl Med. 2014;3:610–9.
Adamowicz J, Kowalczyk T, Drewa T. Tissue engineering of urinary bladder—current state of art and future perspectives. Cent Eur J Urol. 2013;66:202–6.
Sharma AK. An examination of regenerative medicine-based strategies for the urinary bladder. Regen Med. 2011;6:583–98.
Chung SY, Krivorov NP, Rausei V, et al. Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol. 2005;174:353–9.
Zhang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int. 2005;96:1120–5.
Matsunuma H, Kagami H, Narita Y, et al. Constructing a tissue-engineered ureter using a decellularized matrix with cultured uroepithelial cells and bone marrow-derived mononuclear cells. Tissue Eng. 2006;12:509–18.
Imamura T, Yamamoto T, Ishizuka O, Gotoh M, Nishizawa O. The microenvironment of freeze-injured mouse urinary bladders enables successful tissue engineering. Tissue Eng Part A. 2009;15:3367–75.
Sharma AK, Hota PV, Matoka DJ, et al. Urinary bladder smooth muscle regeneration utilizing bone marrow derived mesenchymal stem cell seeded elastomeric poly(1,8-octanediol-co-citrate) based thin films. Biomaterials. 2010;31:6207–17.
Sharma AK, Bury MI, Marks AJ, et al. A nonhuman primate model for urinary bladder regeneration using autologous sources of bone marrow-derived mesenchymal stem cells. Stem Cells. 2011;29:241–50.
Burt RK. Clinical utility in maximizing CD34+ cell count in stem cell grafts. Stem Cells. 1999;17:373–6.
Jack GS, Zhang R, Lee M, Xu Y, Wu BM, Rodríguez LV. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials. 2009;30:3259–70.
Shi JG, Fu WJ, Wang XX et al. Transdifferentiation of human adipose-derived stem cells into urothelial cells: potential for urinary tract tissue engineering. Cell Tissue Res. 2012.
Zhang M, Peng Y, Zhou Z, Zhou J, Wang Z, Lu M. Differentiation of human adipose-derived stem cells co-cultured with urothelium cell line toward a urothelium-like phenotype in a nude murine model. Urology. 2013;81:465. e15-465. e22.
Drewa T, Joachimiak R, Kaznica A, Sarafian V, Pokrywczynska M. Hair stem cells for bladder regeneration in rats: preliminary results. Transplant Proc. 2009;41:4345–51.
Drewa T, Joachimiak R, Bajek A, et al. Hair follicle stem cells can be driven into a urothelial-like phenotype: an experimental study. Int J Urol. 2013;20:537–42.
Shoae-Hassani A, Sharif S, Seifalian AM, Mortazavi-Tabatabaei SA, Rezaie S, Verdi J. Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women. BJU Int. 2013;112:854–63.
Kang HH, Kang JJ, Kang HG, Chung SS. Urothelial differentiation of human amniotic fluid stem cells by urothelium specific conditioned medium. Cell Biol Int. 2014;38:531–7.
De Coppi P, Callegari A, Chiavegato A, et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol. 2007;177:369–76.
Hyndman ME, Kaye D, Field NC, et al. The use of regenerative medicine in the management of invasive bladder cancer. Adv Urol. 2012;2012:653652.
Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res. 2001;49:568–81.
Loai Y, Yeger H, Coz C, et al. Bladder tissue engineering: tissue regeneration and neovascularization of HAVEGF-incorporated bladder acellular constructs in mouse and porcine animal models. J Biomed Mater Res, Part A. 2010;94:1205–15.
Lorentz KM, Yang L, Frey P, Hubbell JA. Engineered insulin-like growth factor-1 for improved smooth muscle regeneration. Biomaterials. 2012;33:494–503.
Bharadwaj S, Liu G, Shi Y, et al. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011;17:2123–32.
Wu R, Liu G, Bharadwaj S, Zhang Y. Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering. In: Organ regeneration. Springer; 2013: 65-80
Sangha N. Isolation of urothelial cells from bladder tissue. In: Organ regeneration. Springer; 2013: 21-33
Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev. 2011;63:300–11.
Liebermann-Meffert D. The greater omentum. Anatomy, embryology, and surgical applications. Surg Clin North Am. 2000;80:275–93.
Schultheiss D, Gabouev AI, Cebotari S, et al. Biological vascularized matrix for bladder tissue engineering: matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol. 2005;173:276–80.
Cartwright L, Farhat WA, Sherman C, et al. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study. J Biomed Mater Res A. 2006;77:390–5.
Nomi M, Miyake H, Sugita Y, Fujisawa M, Soker S. Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther. 2006;1:333–43.
Mondalek FG, Ashley RA, Roth CC, et al. Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: from fabrication to preclinical validation. J Biomed Mater Res A. 2010;94:712–9.
Feil G, Christ-Adler M, Maurer S, et al. Investigations of urothelial cells seeded on commercially available small intestine submucosa. Eur Urol. 2006;50:1330–7.
Bivalacqua T, Steinberg G, Smith N, et al. mp61-16 pre-clinical and clinical translation of a tissue engineered neo-urinary conduit using adipose derived smooth muscle cells for urinary reconstruction. J Urol. 2014;191:e689.
Bivalacqua T, Steinberg G, Smith N et al. 178 pre-clinical and clinical translation of a tissue engineered neo-urinary conduit using adipose derived smooth muscle cells for urinary reconstruction. European Urology Supplements. 2014;13.
Compliance with Ethics Guidelines
Conflict of Interest
Dr. Max Kates, Dr. Anirudha Singh, Dr. Hotaka Matsui, Dr. Gary D. Steinberg, Dr. Norm D. Smith, Dr. Mark P. Schoenberg, and Dr. Trinity J. Bivalacqua each declare no potential conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Regenerative Medicine
Rights and permissions
About this article
Cite this article
Kates, M., Singh, A., Matsui, H. et al. Tissue-Engineered Urinary Conduits. Curr Urol Rep 16, 8 (2015). https://doi.org/10.1007/s11934-015-0480-3
Published:
DOI: https://doi.org/10.1007/s11934-015-0480-3